Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone(®)) increases antibody response, cellular immunity, and antigenically drifted protection

Safe and effective adjuvants for influenza vaccines that could increase both the levels of neutralizing antibody, including against drifted viral subtypes, and T-cell immunity would be a major advance in vaccine design. The JVRS-100 adjuvant, consisting of DOTIM/cholesterol cationic liposome-DNA com...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lay, Marla, Callejo, Bernadette, Chang, Stella, Hong, David K., Lewis, David B., Carroll, Timothy D, Matzinger, Shannon, Fritts, Linda, Miller, Christopher J, Warner, John F., Liang, Lily, Fairman, Jeffery
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2690618/
https://ncbi.nlm.nih.gov/pubmed/19406188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.04.054
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars